** Shares of genetic testing firm 23andMe ME.O fall 42.5% to $1.03 premarket
** On Sunday, ME filed for Chapter 11 bankruptcy protection to facilitate the sale of co
** Co's CEO, Anne Wojcicki, has resigned after her attempts to buy out the company were rejected multiple times
** Wojcicki plans to make another bid to buy the co during the bankruptcy process
** Co has secured $35 mln in financing to continue operating during the sale process
** Co's latest valuation is $50 mln, which is much lower than its $3.5 bln market value when it went public in 2021
** Stock fell 79.5% in the last 12 months
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.